Introduction
Photodynamic therapy (PDT) is a minimally invasive treatment for cancer and several noncancerous proliferating cell diseases (Dougherty et al., 1998; Dougherty, 2002) . It relies on the uptake of a photosensitizing compound by the pathologic tissue followed by a selective irradiation with visible light. PDT dual specificity is characterized by a preferential concentration of the photosensitizer in the target tissue and by a specific light irradiation of the target areas. In the presence of molecular oxygen, the photosensitization reaction generates reactive oxygen species (ROS) (Matroule and Piette, 2000b) , which induce a direct tumour cell death by apoptosis and/or necrosis (Oleinick et al., 2002; Piette et al., 2003) . Several groups have reported the antitumour properties of pheophorbide-and pyropheophorbide-based PDT (Bellnier et al., 1993; Payne et al., 1996; Henderson et al., 1997) . However, PDT also induces the release of proangiogenic factors, such as vascular endothelial growth factor (VEGF), in vitro and in vivo, and promotes the expression of the inducible cyclooxygenase-2 (COX-2) enzyme (Ferrario et al., 2000 (Ferrario et al., , 2002 . The regulation of expression and the tissue distribution of the two main COX isoforms (COX-1 and -2) differ fundamentally (Vane et al., 1998) . COX-1 is ubiquitous and constitutively expressed in many tissues or organs. In contrast, COX-2 is undetectable in most tissues, but its expression can be rapidly induced by a variety of stimuli such as growth factors and cytokines (Morita, 2002) . The bifunctional COX enzyme catalyses the first two committed steps in the pathway leading to generation of various prostanoids, including prostaglandins and thromboxane. COX-2 appears to be involved in the pathogenesis of colon cancer since increased expression of COX-2 is detected in colorectal carcinomas (Gupta and Dubois, 2001 ). COX-2 triggers modifications in tumour cell features, which intensify their tumorigenicity, such as increased adhesion to extracellular matrix proteins, enhanced cell motility, resistance to apoptosis and induction of cell proliferation (Tsujii and DuBois, 1995) . COX-2 overexpression in colon cancer cells also results in the release of large amounts of proangiogenic factors, including VEGF (Tsujii et al., 1998) . This suggests that the use of specific COX-2 inhibitors might be beneficial to the treatment of neoplasm. Accordingly, two recent studies indicate that inhibition of COX-2 potentiates the antitumour effects of PDT in mice (Ferrario et al., 2002; Makowski et al., 2003) . At a molecular level, COX-2 expression is regulated by transcriptional and post-transcriptional events. Transcriptional regulation of the cox-2 gene is directed via several promoter elements binding CRE (cyclic adenosine 3 0 ,5 0 -monophosphate responsive element), nuclear factor kappa B (NF-kB), NF-IL6 and an E-box (Smith et al., 2000) . On the other hand, mitogen-activated protein kinase (MAPK) signalling pathways, particularly p38 (Lasa et al., 2000) , are involved in post-transcriptional regulation through activation of AU-rich element binding proteins, such as HUR (Sengupta et al., 2003) . The molecular mechanisms leading to COX-2 expression after PDT are poorly defined (Hendrickx et al., 2003) . The only reported study demonstrates that hypericin-mediated PDT (HYP-PDT) induces the rapid activation of p38 and a post-transcriptional regulation of COX-2 mRNA without activation of NF-kB. Here, we focus on the molecular mechanisms underlying COX-2 expression in bladder cancer cell line (T24) and in an epithelial cancer cell line (HeLa) after pyropheophorbide-a methyl ester (PPME)-mediated PDT (PPME-PDT). We show that cox-2 gene transcription is upregulated in both cell lines. This transcription is dependent on NF-kB activation through phosphorylation of Ser32 and -36 residues of IkBa by the I kappa B kinase (IKK) complex. In addition, we demonstrate that protein kinase C (PKC)a and phosphoinositide-3-kinase (PI3K) act upstream of NF-kB activation in T24 cells. Our results indicate that the molecular mechanisms modulating COX-2 expression differ with regard to the photosensitizer used and that selective inhibition of NF-kB might be a way to enhance PDT efficiency and to avoid recurrences.
Results

PPME-PDT induces COX-2 expression
PDT-induced COX-2 expression has been previously reported (Ferrario et al., 2002; Hendrickx et al., 2003) . Therefore, we tested the ability of PPME-PDT to induce COX-2 expression in two well-characterized cancer cell lines derived from tissues prone to PDT, HeLa (cervix) and T24 (bladder). These cells were incubated with 5 mM PPME for 15 h and irradiated with increasing doses of red light. Cytoplasmic extracts were prepared 3 h after irradiation and subjected to Western blot analysis ( Figure 1a ). Both cell types exhibit a de novo expression of COX-2, the maximal expression being generated by fluences of 3.2 and 6.4 J/cm 2 . COX-2 was visualized on Western blot either as a single-band or a multiple-band product (Figure 1 ). Multiple bands likely corresponded to COX-2 glycosylation products (Nemeth et al., 2001) . In order to identify the molecular mechanisms responsible for COX-2 expression induced by a sublethal PDT dose, we used 5 mM PPME in combination with a 3.2 J/ cm 2 fluence, corresponding to a 95% survival rate after 24 h (data not shown). PDT-induced COX-2 expression was also evaluated in a time-dependent manner ( Figure 1b) . COX-2 expression occurs 3 h after PDT and is sustained for 24 h in T24 cells, while the COX-2 level decreases between 9 and 12 h to almost return to the basal level after 24 h in HeLa cells.
PPME-PDT triggers NF-kB activation
The transcriptional regulation of cox-2 gene is partially dependent on NF-kB transcription factor (Smith et al., 2000) . An activation of this major transcription factor upon PDT has been already described in several cell lines (Matroule et al., 1999; Volanti et al., 2002) . To evaluate the binding of NF-kB to the kB element of the cox-2 promoter, HeLa and T24 cells were treated by PDT and nuclear extracts were prepared at various times after irradiation and subjected to an electrophoretic mobility shift assay (EMSA) using a specific probe for the NF-kB element of cox-2 promoter or a consensus probe (see Materials and methods) (Figure 2a ). PPME-PDT triggers NF-kB activation in HeLa cells as evidenced by two retarded bands with either probe. Competition experiments with a nonradiolabelled probe indicate that the upper band is specific to NF-kB (data not shown). The single-wave NF-kB activation exhibits a similar kinetic with both probes. NF-kB translocation into the nucleus occurs 1 h after PDT and is maximal between 4 and 6 h to return to the basal level after 24 h. Supershift experiments indicate that, for both probes, the NF-kB complex is constituted of the classical p50/ p65 heterodimer (Figure 2b ). The PDT-treated T24 cells display a biphasic NF-kB activation characterized by (i) an early activation occurring between 5 min and 1 h after PDT and (ii) a late activation 4 h after PDT, which is sustained until 24 h (Figure 2c ). The same pattern of activation has been previously described in HCT116 colon cancer cells, and an autocrine mechanism based on the release of cytokine(s) has been suspected as responsible for this effect (Matroule et al., 1999) . Similar to HeLa, the nature of the NF-kB complex activated in T24 cells after 6 h is p50/p65 heterodimer ( Figure 2d ).
Cox-2 gene is transcriptionally regulated upon PPME-PDT
To investigate the transcriptional potential of NF-kB and the transcriptional activation of cox-2 gene, we chose a strategy based on RT-PCR and transient transfection assays. Unfortunately, T24 cells are very poorly transfectable, thereby restricting our study to the detection of the cox-2 mRNA by RT-PCR in this cell type. HeLa cells were transiently transfected with a kBluciferase reporter construct and subjected to PDT. Luciferase activity was measured in total cell extracts 8 h after treatment (Figure 3a) . The PDT treatment induces a sixfold increase of the luciferase activity, demonstrating that the NF-kB complex is transcriptionally active. Under similar experimental conditions, we also observed a twofold increase of the luciferase activity of a cox-2 promoter-luciferase reporter construct (Figure 3a ). This increase in luciferase activity was suppressed by the addition of BAY11-7085, which inhibits the IKK activity ( Figure 3a) . The transcriptional activation of the cox-2 gene after PDT was confirmed by RT-PCR analysis in both HeLa and T24 cells (Figure 3b ). The cox-2 mRNA was detectable 1 h after irradiation and maintained after 6 h in both cell types.
COX-2 expression is driven by IKK complex activation and IkBa S32-36 phosphorylation A critical step in NF-kB activation is the S32 and S36 phosphorylation of its physiological inhibitor IkBa. These phosphorylations tag the inhibitor for its subsequent degradation by the 26S proteasome, resulting in the nuclear translocation of NF-kB. The phosphorylation of IkBa S32-36 is specifically performed by the IKK complex (Karin and Ben-Neriah, 2000) . To test the involvement of the IKK complex and IkBa S32-36 phosphorylation in PDT-induced COX-2 expression, two sets of experiments were carried out. First, the cells were preincubated for 1 h with increasing concentrations of BAY11-7085, a chemical inhibitor of the IKK complex whose efficiency was verified by EMSA ( Figure 4a ), and the expression of COX-2 was evaluated (Figures 4b and 5a ). Next, we constructed HeLa cells lines expressing either the NF-kB super-repressor IkBa S32-36A (called S32-36A) or IkBa wild type (WT) (also named W2). Both constructs were expressed at the same level and the dominant-negative effect of the S32-36A clone was verified by TNF-a treatment (data not shown). The expression of COX-2 was affected in the S32-36A clone but not in W2 clone (Figure 4c and d) , demonstrating the importance of S32-36 phosphorylation in COX-2 expression. Since the T24 cells were not transfectable, the generation of cell clones expressing IkBa S32-36A or IkBa WT was impossible for the evaluation of the involvement of the IKK complex and the subsequent serine phosphorylation of IkBa. Therefore, T24 cells were preincubated with MG132, a specific 26S proteasome inhibitor, allowing the stabilization of IkBa S32-36P, which was then detected by Western blotting using a specific antibody (Figure 5b ). The phosphorylation is detectable between 5 and 30 min after PDT and is prolonged until 3 h. This observation is reinforced by an in vitro kinase assay demonstrating the GST-IkBa phosphorylation by anti-IKK immunoprecipitates from PDT-treated cells, thereby attesting the IKK complex activation. IKK activation occurred 30 min after photosensitizing the T24 cells and sustained until 3 h with a maximal activity after 2 h (Figure 5c and d). The amount of IKKb was measured by Western blotting as loading control (Figure 5c ). These experiments clearly indicate that, in HeLa and T24 cells, IkBa phosphorylation by the IKK complex is a crucial step for the transcriptional activation of the cox-2 gene. HeLa and T24 cells were treated by PDT (5 mM PPME, 2 J/cm 2 red light irradiation). Control cells incubated with PPME (5 mM) but not irradiated are denoted as ctrl. Total RNAs were isolated at various times after treatment. RNAs were analysed by RT-PCR with specific primers for COX-2 and GAPDH. PCR products were resolved on agarose gel and stained with ethidium bromide Figure 4 Inhibition of NF-kB activation decreases the level of COX-2 expressed in HeLa cells after PPME-PDT. (a) HeLa cells were preincubated for 1 h with increasing dose of BAY11-7085, treated by PDT (5 mM PPME and 3.2 J/cm 2 red light irradiation) and returned back in culture with BAY11-7085. After 3 h, cytoplasmic extracts were prepared, and analysed by Western blotting with a specific antibody for COX-2. (b, c) HeLa cells expressing the NF-kB super-repressor HA-IkBa S32-36A (called S32-36A) or HA-IkBa WT (called W2) were generated. The two clones express exogenous proteins in the same amount. HeLa cells (b, c), S32-36A cell line (b) and W2 cell line (c) were untreated (ctrl) or treated by PDT (5 mM PPME and 3.2 J/cm 2 red light irradiation). At various times after treatment, cytoplasmic extracts were prepared, and analysed by Western blotting with a specific antibody for COX-2 COX-2 expression in tumour cells after PDT C Volanti et al
PKC is implicated in PPME-PDT-induced COX-2 expression in T24 cells
Several PKC isoforms have been associated to the signalling pathway modulating COX-2 expression in many cell lines (Kim and Chun, 2003; Khan et al., 2004 ). Therefore, we tested their participation in PDT-induced COX-2 expression. HeLa and T24 cells were preincubated with various concentrations of two PKC inhibitors: Go¨6976 and Go¨6983. Go¨6976 selectively inhibits Ca 2 þ -dependent PKCa and PKCb1 isoforms and PKCm (also known as PKD), whereas Go¨6983 is a potent inhibitor of PKCa, b, g, d and z but not of PKD (Wang et al., 1998) . Preincubation of HeLa cells with both inhibitors does not modify the level of PDT-induced COX-2 expression (Figure 6 ), excluding PKCs and PKD from the COX-2 activation pathway. Conversely, preincubation of T24 cells with either Go¨6976 or Go¨6983 decreases, in a dose-dependent manner, the level of COX-2. These results unambiguously demonstrate that PKCa or PKCb1 isozymes are implicated in COX-2 expression after PPME-PDT in T24 cells.
PKC acts upstream the IKK complex and NF-kB activation
Since PDT-induced COX-2 expression is dependent on NF-kB, we sought to determine PKC position in the transduction pathway leading to NF-kB activation. Pretreatment of T24 cells with 200 nM Go¨6976 totally abolishes the PDT-induced NF-kB activation (Figure 7a) , whereas TNF-a-induced NF-kB activation is not affected by Go¨6976. Because NF-kB activation pathway is a multistep process, we next evaluated whether PKC acts upstream or downstream the IKK complex. To clarify the PKC's position in this pathway, two sets of experiments were carried out. First, T24 cells were treated with 200 nM Go¨6976 and subjected to an in vitro IKK activity assay at various times after PDT. The PDT-induced but not the TNF-a-induced IKK activation was abolished by Go¨6976 (Figure 7b and c) . Next, we assessed the in vivo PDT-induced phosphorylation of the S32-36 of IkBa with or without PKC inhibitor treatment. T24 cells were pretreated with 200 nM Go¨6976 and 10 mM MG132 before PDT treatment. Consistent with the above observations, treatment with Figure 5 PDT induces IKK activity and NF-kB-dependent COX-2 transcription. (a) T24 cells were preincubated for 1 h with increasing dose of BAY11-7085, treated by PDT (5 mM PPME and 3.2 J/cm 2 red light irradiation) and returned back in culture with BAY11-7085. After 3 h, cytoplasmic extracts were taken and analysed by Western blotting with a specific antibody for COX-2. (b) T24 cells were untreated (ctrl), treated with TNF-a (200 U/ml) or treated by PDT (5 mM PPME and 3.2 J/cm 2 red light irradiation). Cells were preincubated with MG132 (10 mM). Protein extracts were prepared at various times after irradiation, and analysed by Western blotting with a specific antibody for the S32-36 phosphorylated form of IkBa. (c, d) T24 cells were untreated (ctrl), treated with TNF-a (200 U/ml) or treated by PDT (5 mM PPME and 3.2 J/cm 2 red light irradiation). Protein extracts were taken at various times after irradiation and the IKK complex was immunoprecipitated with an IKKg antibody. Immunoprecipitates were subjected to an IKK assay with GST-IkBa (1-54) as substrate. After kinase reaction, proteins were analysed by Western blotting with a specific antibody for the S32-36 phosphorylated form of IkBa or with an antibody for IKKb. (d) Quantitative densitometric analysis of the IKK activity. Results are expressed in fold induction and corrected for the amount of IKKb Figure 6 PKCs are involved in COX-2 expression after PPME-PDT in T24 but not in HeLa cells. T24 and HeLa cells were preincubated or not for 1 h with increasing dose of Go¨6976 or Go¨6983, left untreated (ctrl) or treated by PDT (5 mM PPME and 3.2 J/cm 2 red light irradiation). Cytoplasmic extracts were taken 3 h after the irradiation and analysed by Western blotting with a specific antibody for COX-2 COX-2 expression in tumour cells after PDT C Volanti et al PKC inhibitor abolishes the PDT-induced phosphorylation of IkBa (Figure 7d) . These experiments strongly suggest that PKC acts upstream the IKK complex.
PDT induces the activation of PKCa isoform
The activation of the Ca 2 þ -stimulated PKCa isoform has been shown to be dependent on its translocation from cytoplasm to plasma membrane. Hence, we verified the involvement of PKCa in the transduction pathway leading to COX-2 upregulation by PDT in T24 cells, by investigating its intracellular redistribution to the plasma membrane. The analysis of cytosolic and membrane protein fractions from PDT-or phorbol 12-myristate 13-acetate (PMA)-treated cells reveals a translocation of PKCa from the cytosol to the membrane (Figure 8a ). The maximal translocation occurs between 5 and 30 min after PDT, but a significant amount of membrane-bound enzyme is still detectable after 3 h. Western blot analysis with IkBa and fibronectin antibodies demonstrated the lack of crosscontamination between membrane and cytosolic extracts (Figure 8b ).
PI3K is involved in PDT-induced COX-2 expression
It has been recently reported that PI3K and the subsequent AKT phosphorylation/activation participate in COX-2 activation upon UVB irradiation (Tang et al., 2001) . Since the PI3K pathway leads to several PKC isoforms activation, we evaluated the implication of PI3K in PDT-induced COX-2 expression. Pretreatment of T24 cells with increasing concentrations of the PI3K inhibitor LY294002 strongly decreases the level of COX-2 (Figure 9a ). Furthermore, PDT induces a rapid phosphorylation of the S241 residue of PH domain kinase (PDK)-1 (2.7-fold increase), the major downstream kinase of PI3K, which persists at least for 2 h after treatment (Figure 9b) . One of the major pathways induced by PI3K activation is the AKT pathway. A strong phosphorylation of the S473 residue of AKT is observed between 30 min and 2 h after PDT (Figure 9c ). AKT phosphorylation is maximal at 30 min and then levelled off at 3 h post-treatment. In order to determine the role of AKT in PDT-induced COX-2 expression, T24 cells were infected with an adenoviral vector expressing an HA-tagged dominant-negative form of AKT (AKT DN) or an empty adenoviral vector and subjected to PDT treatment (Figure 9d ). Expression of AKT DN does not substantially modify PDT-induced COX-2 expression, suggesting that AKT is not part of the signalling pathway leading to COX-2 upregulation. In order to clarify the position of PI3K relative to PKCa, PKCa translocation into the membrane was evaluated by Western blotting in PDT-treated T24 cells preincubated with LY294002 (Figure 9e ). PKCa translocation is strongly reduced when T24 cells are incubated in the presence of the PI3K inhibitor, indicating that PI3K acts upstream PKCa. 
Discussion
In the present work, we analysed the molecular mechanisms underlying COX-2 expression in two cancer cell lines, namely HeLa and T24, in response to PPME-PDT. We have unambiguously demonstrated that PDT-induced COX-2 expression results from the transcriptional activation of the cox-2 gene. The transcription factor NF-kB plays a major role in this activation since it is activated in both cell lines and binds to the kB element of the cox-2 promoter. These observations are consistent with previous studies reporting a transcriptional activation of cox-2 in RIF cells after Photofrin-PDT (Ferrario et al., 2002) . COX-2 expression was also described in T24 and HeLa cells after HYP-PDT (Hendrickx et al., 2003) . In this study, HYP-PDT induces a strong and rapid NF-kB-independent cox-2 activation. In addition, pretreatment with BAY11-7085 does not alter the kinetic and the extent of COX-2 expression in cells exposed to HYP-PDT. Similar results were obtained in HeLa cells overexpressing IkBa. HYP-PDT-induced COX-2 expression is dependent on the p38 MAPK activation leading to the COX-2 mRNA stabilization. However, pretreatment of HeLa and T24 cells with specific p38 inhibitors does not affect COX-2 expression in response to PPME-PDT (data not shown). The discrepancy between these findings and our observations is surprising considering the similar subcellular localization of HYP and PPME (Matroule et al., 1999; Hendrickx et al., 2003) ; however, the chemical nature of the photosensitizers is probably the determinant. While PPME-PDT induces NF-kB activation in various cell lines (Matroule and Piette, 2000a; Volanti et al., 2002) , no NF-kB activation is observed upon HYP-PDT (Hendrickx et al., 2003) . In addition, HYP has been described as an NF-kB inhibitor in HeLa and T10 cells after UVB, PMA or TNF-a stimulation (Bork et al., 1999; Taher et al., 2002) . This was confirmed in this work by the absence of p38, JNK and Erk-1,2 activation in both HeLa and T24 cells photosensitized by PPME. The two members of the atypical PKC subfamily (PKCz and PKCl/i) are involved in the control of NF-kB through IKKb activation Sanz et al., 1999) . The conventional PKC isoform PKCa, but not PKCb1, is also required for the activation of the IKK complex upon T-cell activation triggered by CD3/CD28 crosslinking (Trushin et al., 2003) . Another recent study has proposed an elegant model in which TNF-a binding to the TNFR1 activates PI-PLCg to induce PKCa and c-Src activation leading to tyrosine phosphorylation of IKKa/b (Huang et al., 2003) . Recently, a ROS-induced NF-kB activation in HeLa cells has been shown to involve phosphorylation of Y463 and S738-742 of PKD by Src-Abl and PKCs, respectively (Storz and Toker, 2003) . These two events fully activated PKD, which, in turn, induced IKKb activation (Storz and Toker, 2003) . In the present work, we investigated the involvement of PKC and PKD in NF-kB activation and COX-2 expression in response to PDT-generated ROS. Using specific PKC inhibitors, we unambiguously demonstrate that PKCs are involved in NF-kB activation in T24 but not in HeLa cells. PKC, at least PKCa, acts upstream the IKK complex and is necessary to induce IkBa phosphorylation, NF-kB nuclear translocation and COX-2 expression. PKD does not seem to be involved in this pathway, since Go¨6983 exhibits similar effects to Go¨6976. Further experiments are still needed to totally rule out the PKD involvement since its activation could be PKC dependent.
The PI3K pathway is also involved in NF-kB activation and COX-2 expression. Two studies indicate that AKT, either in the context of TNF-a signalling or in response to growth factor, stimulates NF-kB nuclear translocation via the activation of the IKK complex (Ozes et al., 1999; Romashkova and Makarov, 1999) . IL-1b activates the p65 transcriptional activation domain and induces phosphorylation of p65 in an AKT-dependent manner (Sizemore et al., 1999) . AKT targets the transactivation function of NF-kB by stimulating the activation domain of p65 via IKKb and p38 activities. Activation of p65 transactivation function requires S529 and S536 phosphorylation (Madrid et al., 2000 (Madrid et al., , 2001 . In Raw 264.7 murine macrophage, catalase induces the expression of COX-2 through the transcriptional activation of NF-kB and the PI3K pathway, where PI3K stabilizes the cox-2 mRNA (Jang et al., 2004) . Here, we show that PI3K activation is required for COX-2 expression after PDT in T24 cells but not in HeLa cells. Moreover, we showed that both PDK-1 and AKT were phosphorylated after PDT. À7 M PMA or treated by PDT (5 mM PPME and 3.2 J/cm 2 red light irradiation). Cytosolic and membrane protein extracts were prepared at various times after irradiation, and analysed by Western blotting with a specific antibody for PKCa. Results are presented as densitometric analysis of the amount of PKCa corrected by the amount of total proteins detected by Coomassie blue staining. (b) Western blot analysis of the absence of crosscontamination in the membrane and cytosolic extracts using IkBa and fibronectin antibodies, respectively COX-2 expression in tumour cells after PDT C Volanti et al
Using an adenoviral vector, we demonstrate that despite the AKT activation in response to PDT, this kinase is not involved in COX-2 expression. Since PPME-PDTinduced COX-2 expression is purely transcriptional and NF-kB dependent, we propose that PI3K and likely PDK-1 are the upstream mediators of this pathway leading to NF-kB activation. The PI3K activation leading to the direct activation of PDK-1 (an AGC family S/T kinase member), which is well known to be the upstream kinase for the activation loop of PKCs (Dempsey et al., 2000) , likely leads to PKCa activation and subsequently to NF-kB activation and COX-2 expression.
The dichotomy in NF-kB activation pathway between T24 and HeLa cells is also one of the major findings of our work (Figure 10 ). However, since it has been demonstrated that small G proteins of the Ras and Rho family are particularly important for PI3K function (Deane and Fruman, 2004) and that T24 cells exhibit an oncogenic H-ras mutation (Flatow et al., 1987) , this could be an explanation for the difference between the two cell lines.
In conclusion, in this work we show that PPME-PDT, in nonlethal conditions, induces the expression of COX-2 in two cancer cell lines. Expression of COX-2 is purely transcriptional and NF-kB dependent. Moreover, for the first time, we report a PI3K-PKC-IKK-dependent activation of NF-kB in a cancer bladder cell line after PDT.
Materials and methods
Chemicals and reagents PPME and MG132 were from Sigma. BAY11-7085 was from Biomol. LY294002, Go¨6976 and Go¨6983 were from Calbiochem. Radiolabelled nucleotides were from NEN Life Science. The reagents were reagent grade.
Light source
The light source used was a halogen lamp combined with a red filter (l>600 nm) giving a fluence rate of 160 W/m 2 .
Plasmids
The pNF-kB-Luc reporter gene construct contains five repeats of the kB site from the HIV-1 LTR cloned upstream the luciferase gene (Stratagene). Figure 9 PI3K is activated in T24 cells after PPME-PDT and is important for COX-2 expression. (a) T24 cells were preincubated for 1 h with increasing doses of LY294002. Cells were left untreated (ctrl) or treated by PDT (5 mM PPME and 3.2 J/cm 2 red light irradiation). Protein extracts were prepared 3 h after irradiation, and analysed by Western blotting with a specific antibody for COX-2. (b) T24 cells were left untreated (ctrl) or treated by PDT (5 mM PPME and 3.2 J/cm 2 red light irradiation). Protein extracts were prepared at various times after irradiation, and analysed by Western blotting with a specific antibody for the phosphorylated S241 form of PDK-1 and for PDK-1. (c) T24 cells were left untreated (ctrl), treated with EGF or treated by PDT (5 mM PPME and 3.2 J/cm 2 red light irradiation). Protein extracts were prepared 3 h after irradiation, and analysed by Western blotting with a specific antibody for the phosphorylated S473 forms of AKT. (d) T24 cells were infected by either an HA-tagged AKT DN adenoviral vector (AKT DN) or an empty adenoviral vector (Uge) and treated by PDT (5 mM PPME and 3.2 J/cm 2 red light irradiation) or left untreated. Protein extracts were prepared 3 h after irradiation and analysed by Western blotting with specifics antibodies for COX-2, HA and AKT. (e) T24 cells were preincubated for 1 h with 20 mM of LY294002 or with 200 nM of Go¨6976. Cells were left untreated (ctrl) or treated by PDT (5 mM PPME and 3.2 J/cm 2 red light irradiation). Cytosolic protein extracts were taken 2 h after irradiation and analysed by Western blotting with a specific antibody for PKCa. Results are presented as densitometric analysis of the amount of PKCa corrected by the amount of total proteins detected by Coomassie blue staining COX-2 expression in tumour cells after PDT C Volanti et al
Adenoviral vector
The adenoviral vector AKT DN and the empty adenoviral vector were a gift from Dr M Garmyn (KU Leuven, Belgium).
Cell exposure to PPME photosensitization Cell exposure to PPME photosensitization was performed as previously described (Volanti et al., 2002) .
mRNA expression studies
Cells were washed twice in cold PBS, scraped in cold PBS, centrifuged at 3000 g for 2 min and directly frozen at À801C. Total mRNAs were obtained using the TRIPUR extraction kit (Roche). RNAs were treated with DNAse I (Roche) for 20 min at 371C in DNAse I buffer (100 mM Tris, 100 mM MgCl 2 , pH 7.6). A 1 mg portion of RNAs was then subjected to reverse transcription in 15 ml reaction mixture containing 2.5 mM random primers (Amersham Pharmacia Biotech), 16 mM DTT (Life Technologies), 1.6 mM dNTPs (Roche), 0.35 ml RNA guard (Amersham Pharmacia Biotech), 250 U of Moloney murine leukaemia virus reverse transcriptase (Life Technologies) and first strand buffer (Life Technologies). RT-PCR analyses were performed with specific primers for COX-2 and GAPDH.
Nuclear and cytoplasmic protein extracts
Nuclear extracts were prepared as previously described (Volanti et al., 2002) .
Total protein extract for phospho Western blotting
At various times after treatment, cells were washed twice with ice-cold PBS. Cells were scraped in 200 ml of lysis buffer (25 mM HEPES, 1% Triton X-100, 10% glycerol, 300 mM NaCl, 1.5 mM MgCl 2 , 2 mM EDTA, 2 mM EGTA, 1 mM DTT, 1 mM PMSF, 25 mM b-glycerophosphate, 1 mM Na 3 VO 4 , 50 mM NaF and protease inhibitor (Completet, Roche)) and centrifuged for 15 min at 15 000 g at 41C. Supernatants were immediately frozen at À801C.
Cytosolic and membrane extracts
Cells were washed twice, scraped in cold PBS and centrifuged at 2000 g for 5 min at 41C. The pellets were resuspended in 200 ml of TpI (10 mM Tris-HCl pH 7.4, 1 mM EDTA, 200 mM sucrose, 1 mM PMSF, 1 mM DTT and protease inhibitor cocktail Completet) and centrifuged at 900 g for 10 min at 41C. Supernatants were collected and centrifuged at 110 000 g for 75 min at 41C. The supernatants, which contained cytosolic extract, were immediately frozen. The pellets were resuspended in 30 ml of TpII (10 mM Tris-HCl pH 7.4, 1 mM EDTA, 0.5% Triton X-100, 1 mM PMSF, 1 mM DTT and protease inhibitor cocktail Completet), incubated for 1 h on ice and centrifuged at 14 000 g for 10 min. The supernatants containing membrane protein fractions were immediately frozen.
Electrophoretic mobility shift assays
Nuclear extracts were obtained as described above. EMSA was performed as previously described (Volanti et al., 2002) . The sequences of the probes (Eurogentec) used in this work are as follows: NF-kB consensus probe: 5 0 -GGTTACAAGGGACT TTCCGCTG-3 0 and COX-2 NF-kB probe: 5 0 -TTGGCGG GGCCGCAGGGAATCCCCTCTCCCG-3 0 .
Transient transfection assays
HeLa cells were cultured to a confluence of about 80%. Cells were transfected with FugeneVI (Roche) following the manufacturer's recommendation. Transfected cells were incubated for 24 h in culture medium containing the liposome/ DNA complexes before treatment.
Immunoprecipitation
IKK complex Cytoplasmic extracts (250 mg) were prepared as described above in a hypotonic buffer supplemented with 1 mM Na 3 VO 4 , 5mM NaF, 2 mM b-glycerophosphate and protease inhibitor (Completet, Roche) and were incubated in the immunoprecipitation buffer (50 mM Tris-HCl pH 8.0, 250 mM NaCl, 3 mM EDTA, 3 mM EGTA, 0.1% NP-40, 1 mM DTT, 1 mM PMSF, 1 mM Na 3 VO 4 , 10 mM NaF, 25 mM bglycerophosphate and protease inhibitor cocktail Completet) with 1 mg of anti-IKKg antibody (Santa Cruz Biotechnology) and 40 ml of protein A-Sepharose (Pharmacia Biotech) overnight at 41C. Immunoprecipitated proteins were collected by centrifugation.
IkBa At various times after treatment, cells were washed with ice-cold PBS. Cells were scraped in 200 ml of lysis buffer (25 mM HEPES, 1% Triton X-100, 10% glycerol, 150 mM NaCl, 1 mM DTT, 25 mM b-glycerophosphate, 1 mM Na 3 VO 4 , 5 mM NaF, 5 mM NPP and protease inhibitor (Completet, Roche)) and centrifuged for 15 min at 15 000 g at 41C. Protein concentrations were measured with the Bio-Rad protein assay (Bio-Rad). A 500 mg portion of proteins was incubated in the same buffer with 1 mg of IkBa antibody (Santa Cruz Biotechnology) and 30 ml of protein A-agarose (Santa Cruz Biotechnology) overnight at 41C. Immunoprecipitated proteins were collected by centrifugation. 
In vitro IKK kinase assay
Protein immunoprecipitations were carried out as described above. Then, the proteins were washed three times in immunoprecipitation buffer and twice in kinase buffer (50 mM Tris-HCl pH 8.0, 100 mM NaCl, 2 mM MgCl 2 , 1 mM DTT, 1 mM PMSF, 1 mM Na 3 VO 4 , 10 mM NaF, 25 mM bglycerophosphate, 10 mM NPP and Completet). Immunoprecipitated proteins were then resuspended in 40 ml of kinase buffer supplemented with 1 mM ATP in the presence of 500 ng of WT GST-IkBa (1-54) (gift from R Gaynor, University of Texas, Dallas) and were incubated for 30 min at 301C. The reaction was stopped by the addition of SDS loading buffer and subjected to SDS-PAGE. The detection of phosphorylated GST-IkBa (1-54) was performed by Western blotting with a specific antibody raised against IkBa phospho-S32-36.
Western blotting
COX-2, IkBa phospho-S32-36, IkBa phospho-Y, AKT phospho-S473 and PKCa were detected by Western blotting using specific antibodies. The membranes were incubated with anti-COX-2 (goat polyclonal 1 : 500 dilution, Santa Cruz Biotechnology), anti-IkBa phospho-S32-36 (monoclonal 1 : 500 dilution, Cell Signaling), anti-phosphotyrosine (monoclonal 1 : 1000 dilution, UBI), anti-AKT phospho-S473 (rabbit polyclonal 1 : 100 dilution, Abcam) and anti-PKCa (monoclonal 1 : 1000 dilution, BD) antibodies for 3 h. Membranes were then washed and incubated with the second peroxidaseconjugated antibody. The reaction was revealed with the enhanced chemiluminescence detection method (ECL kit, Amersham).
Abbreviations PDT, photodynamic therapy; VEGF, vascular endothelial growth factor; COX, cyclooxygenase; NF-kB, nuclear factor kappa B; IKK, I kappa B kinase; PKC, protein kinase C; PI3K, phosphoinositide-3-kinase; ROS, reactive oxygen species; MAPK, mitogen-activated protein kinase; ARE, AU-rich element; HYP, hypericin; PPME, pyropheophorbide a methyl ester; LTR, long terminal repeat; HIV, human immunodeficiency virus; EMSA, electrophoretic mobility shift assay; PDK-1, PH domain kinase.
